PSMB9 and nasopharyngeal carcinoma: Type II latency corresponds to the expression, in germinal centers, of EBNA1, LMP1, LMP2, non-coding EBER RNAs and miRNA and is found in EBV-associated Hodgkin lymphomas and nasopharyngeal carcinomas (NPC).